(Q53333738)

13 May 2018

title

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. (English)

1 reference

13 May 2018

0 references

0 references

2

Henrik Zetterberg

1 reference

13 May 2018

3

Kaj Blennow

1 reference

13 May 2018

Jan Jessen Krut

1

1 reference

13 May 2018

Paola Cinque

4

1 reference

13 May 2018

Lars Hagberg

5

1 reference

13 May 2018

Richard W Price

6

1 reference

13 May 2018

Marie Studahl

7

1 reference

13 May 2018

Magnus Gisslén

8

1 reference

13 May 2018

publication date

9 October 2012

1 reference

13 May 2018

published in

Journal of Neurology

1 reference

13 May 2018

volume

260

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

620-626

1 reference

13 May 2018

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

1 reference

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Total and phosphorylated tau protein as biological markers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Amyloid beta and APP as biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

PET imaging of amyloid deposition in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Association of complement factor H Y402H gene polymorphism with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Updated research nosology for HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Herpes simplex virus interferes with amyloid precursor protein processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum protein concentration gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Axonal injury, a neglected cause of CNS damage in bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Lyme neuroborreliosis: infection, immunity, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Herpes simplex virus type 1 in brain and risk of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

CSF amyloid beta42 and tau levels correlate with AIDS dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

Acute Viral Encephalitis in Adults?a Prospective Study

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00415-012-6688-Y

21 January 2018

12 December 2020

HSV-1 promotes Ca2+ -mediated APP phosphorylation and Aβ accumulation in rat cortical neurons

1 reference

12 December 2020

Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid

1 reference

12 December 2020

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

12 December 2020

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

1 reference

12 December 2020

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1 reference

12 December 2020

Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1.

1 reference

12 December 2020

Herpes simplex virus type 1 in Alzheimer's disease: the enemy within

1 reference

12 December 2020

10.1007/S00415-012-6688-Y

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018